香港交易所集团行政总裁陈翊庭：今年香港市场医疗健康领域的IPO融资格外活跃

证券日报10-30

本报讯（记者毛艺融）由香港交易所与中国医药创新促进会联合主办的第十届中国医药创新与投资大会于10月26日至10月27日在南京成功举办。　　香港交易所集团行政总裁陈翊庭表示：“在中国创新药企业加速全球化布局的进程中，资本市场发挥着重要的助推作用。香港交易所一直致力于打造高效、多元的国际融资平台，为中国生物科技企业的发展注入资本动能。今年以来，香港市场医疗健康领域的IPO融资格外活跃，融资额在全球...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2579149059?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-10-30 20:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579149059","market":"hk","top_or_hot":-1,"title":"香港交易所集团行政总裁陈翊庭：今年香港市场医疗健康领域的IPO融资格外活跃","media":"证券日报","content":"<div>\n<p>本报讯 （记者毛艺融）由香港交易所与中国医药创新促进会联合主办的第十届中国医药创新与投资大会于10月26日至10月27日在南京成功举办。　　香港交易所集团行政总裁陈翊庭表示：“在中国创新药企业加速全球化布局的进程中，资本市场发挥着重要的助推作用。香港交易所一直致力于打造高效、多元的国际融资平台，为中国生物科技企业的发展注入资本动能。今年以来，香港市场医疗健康领域的IPO融资格外活跃，融资额在全球...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202510303550596196.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>香港交易所集团行政总裁陈翊庭：今年香港市场医疗健康领域的IPO融资格外活跃</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n香港交易所集团行政总裁陈翊庭：今年香港市场医疗健康领域的IPO融资格外活跃\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-30 20:14 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202510303550596196.html><strong>证券日报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>本报讯 （记者毛艺融）由香港交易所与中国医药创新促进会联合主办的第十届中国医药创新与投资大会于10月26日至10月27日在南京成功举办。　　香港交易所集团行政总裁陈翊庭表示：“在中国创新药企业加速全球化布局的进程中，资本市场发挥着重要的助推作用。香港交易所一直致力于打造高效、多元的国际融资平台，为中国生物科技企业的发展注入资本动能。今年以来，香港市场医疗健康领域的IPO融资格外活跃，融资额在全球...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202510303550596196.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0630378692.HKD","symbol_name":"HSBC GIF ASIA PACIFIC EX JAPAN EQ HD \"AM2\" (HKD) INC","start_time":0,"source_url":"http://finance.eastmoney.com/a/202510303550596196.html","article_id":"2579149059","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579149059","pubTimestamp":1761826444,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"本报讯（记者毛艺融）由香港交易所与中国医药创新促进会联合主办的第十届中国医药创新与投资大会于10月26日至10月27日在南京成功举办。香港交易所集团行政总裁陈翊庭表示：“在中国创新药企业加速全球化布局的进程中，资本市场发挥着重要的助推作用。香港交易所一直致力于打造高效、多元的国际融资平台，为中国生物科技企业的发展注入资本动能。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"80388":"香港交易所-R","LU0630378692.HKD":"HSBC GIF ASIA PACIFIC EX JAPAN EQ HD \"AM2\" (HKD) INC","LU1048596156.SGD":"Blackrock Asian Growth Leaders A2 SGD-H","LU0630378429.USD":"HSBC GIF ASIA PACIFIC EX JAPAN EQ HD \"AM2\" (USD) INC","00388":"香港交易所","BK4585":"ETF&股票定投概念","HKXCY":"香港交易所ADR","XLV":"健康照护类股ETF-SPDR","LU0561508036.HKD":"ALLIANZ CHINA EQUITY \"A\" (HKD) INC","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","BK1521":"挪威政府全球养老基金持仓","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0577902298.EUR":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (EUR) ACC","LU0048580855.USD":"富达大中华区A","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD","LU0873338254.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) INC","XBI":"SPDR S&P Biotech ETF","LU0856984785.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"ACH\" (SGDHDG) ACC","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","LU0577902371.SGD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (SGD) ACC","LU0979878070.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"A\" (USD) ACC","LU1051768304.USD":"贝莱德新兴市场股票收益A6","LU0359201612.USD":"贝莱德中国基金A2","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","SG9999002463.SGD":"LionGlobal China Growth SGD","LU0196878994.USD":"MANULIFE GF CHINA VALUE \"AA\" (USD) INC","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU0096374516.USD":"CT (LUX) I ASIA EQUITY INCOME \"DU\" (USD) ACC","BK4588":"碎股","LU0540923850.HKD":"ALLIANZ HONG KONG EQUITY \"A\" (HKD) INC","LU0605514214.HKD":"FIDELITY CHINA CONSUMER \"A\" (HKD) ACC","LU0797268264.HKD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (HKD) ACC","LU0048597586.USD":"富达亚洲焦点A","LU1515016050.SGD":"Blackrock Emerging Markets Equity Income A6 SGD-H","LU0261947096.USD":"FIDELITY FUNDS  SUSTAINABLE ASIA EQUITY \"A\" (USD) ACC","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","LU1226287529.USD":"UBS (LUX) KEY SELECTION SICAV - CHINA ALLOCATION  OPPORTUNITY (USD) \"P\" (USD) ACC","LABU":"三倍做多标普生物-Direxion","LU0149721374.USD":"HSBC GIF HONG KONG EQUITY \"AD\" INC","LU0061477393.USD":"CT (LUX) I ASIA EQUITY INCOME \"AU\" (USD) ACC","LU1504937902.USD":"CT (LUX) I ASIAN EQUITY INCOME \"DUP\" (EUR) INC","LU0791591158.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"I\" (USD) ACC","LU0762541174.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED INCOME \"AM2\" (USD) INC","LU0052750758.USD":"富兰克林中国基金A Acc","LU0488056044.USD":"Allianz Asian Multi Income Plus Cl AM DIS USD","LU0831093199.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED INCOME \"AM3\" (SGDHDG) INC","LU0384037296.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AT\" (USD) ACC"},"translate_title":"Chen Yiting, Chief Executive Officer of HKEX Group: IPO financing in the medical and health sector in the Hong Kong market has been particularly active this year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"80388":0.6,"LABU":0.6,"XLV":1.5,"XBI":0.6,"HEXmain":0.6,"HKXCY":0.6,"00388":1.5},"content_text":"本报讯 （记者毛艺融）由香港交易所与中国医药创新促进会联合主办的第十届中国医药创新与投资大会于10月26日至10月27日在南京成功举办。　　香港交易所集团行政总裁陈翊庭表示：“在中国创新药企业加速全球化布局的进程中，资本市场发挥着重要的助推作用。香港交易所一直致力于打造高效、多元的国际融资平台，为中国生物科技企业的发展注入资本动能。今年以来，香港市场医疗健康领域的IPO融资格外活跃，融资额在全球新股市场中排名第一。”　　香港交易所亚洲区上市发行服务部主管张书明表示：“香港的医疗健康融资市场近期表现亮眼，这得益于监管制度持续优化，高质量创新企业持续上市，以及投资者积极参与这三大互相紧扣的因素。2025年市场明显回暖，香港重新成为生物科技企业首选的上市目的地。截至目前，香港已完成12宗生物科技IPO，合计融资13亿美元，融资总额位居全球首位。与此同时，生物科技板块的再融资交易也十分活跃，年初至今再融资总额已达41亿美元。这反映了市场信心正逐步恢复，也体现出政策支持和资本市场改革逐步显效。”（文章来源：证券日报）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2579149059","isCrawlerRequest":true}